These results are consistent with a previous study in which ALS mice expressing SOD1 with the G37R mutation4 were treated orally with CuII(atsm)8 and a more recent study in which CuII(atsm) was administered to SOD1G93A mice via a transdermal route10. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.